AAV-CRISPR-Cas9 was used to disrupt the hepatic LDLR gene in adult mice, leading to severe hypercholesterolemia and atherosclerotic lesion in the aortas of C57BL/6J mice [97]. Here, LDLR is linked to Hypercholesterolemia.